Expanded CGM Access Could Usher in New Era of Diabetes Management

Expansions in access by the Centers of Medicare and Medicaid Services could bring the latest advances in continuous glucose monitoring into the hands of millions with diabetes, which could provide significant, population-level impact and bring the field a step closer to equitable diabetes management.

Related Keywords

United States ,American ,Christine Schumacher ,Medtronic Minimed ,Eliud Kipchoge ,Medtronic Guardian ,Williamt Dahms ,Eugene Wright ,Rose Gubitosi Klug ,Abbott Mediaroom ,Complications Trial Research Group ,National Institute Of Diabetes ,Diabetes Study University Hospitals ,Medicaid Services ,University Hospitals ,Charlotte Area Health Education Center ,American Diabetes Association ,Centers For Medicare ,Drug Administration ,Study Research Group ,Medtronic ,Pharmacy Practice ,Care Residency Program ,Midwestern University College ,Continuous Glucose Monitor System ,Freestyle Libre ,Performance Improvement ,Duke University Medical Center ,Glycemic Control Offers ,Diabetes Control ,Complications Trial ,National Institute ,Kidney Diseases ,New England Journal ,Pediatric Endocrinology ,Libre Sense Glucose Sport Biosensors ,Idaho State University ,New Medicare ,Medicare Coverage Requirements Make ,More Accessible ,Glucose Monitoring Devices ,Future Focus ,Diabetes Interventions ,Study Research ,Intensive Diabetes Treatment ,Cardiovascular Outcomes ,Plays Pivotal Role ,Landmark Type ,Continuous Glucose Monitoring Data Interpretation ,Recommendations From ,International Consensus ,Libre Sense ,Cgm ,Continuous Glucose Monitoring ,Access ,Fda ,Cms ,